Evidence map›Paper›PMID 25887307›Full record

ArticleOrphanet journal of rare diseases2015

Familial Mediterranean fever without MEFV mutations: a case-control study.

Ilan Ben-Zvi, Corinne Herskovizh, Olga Kukuy, Yonatan Kassel, Chagai Grossman, Avi Livneh

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Screening for Fabry's disease in a high-risk subpopulation of FMF.European journal of medical research · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Article
  19. Autoinflammatory Diseases in ChildhoodBalkan medical journal · 2020
    Article
  20. Complexity of familial Mediterranean fever genetics.European journal of rheumatology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ilan Ben-ZviDepartment of Medicine F, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. Ilan.Benzvi@sheba.health.gov.il.
Corinne HerskovizhDepartment of Medicine F, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. corinne.del@gmail.com.
Olga KukuyInstitute of Nephrology and Hypertension, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. Olga.Kokoi@sheba.health.gov.il.
Yonatan KasselDepartment of Medicine F, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. yonatankassel@gmail.com.
Chagai GrossmanDepartment of Medicine F, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. Grossman.Chagai@sheba.health.gov.il.
Avi LivnehDepartment of Medicine F, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. Avi.Livneh@sheba.health.gov.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough familial Mediterranean fever (FMF) was originally defined as an autosomal recessive disorder, approximately 10-20% of FMF patients do not carry any FMF gene (MEFV) mutations. Fine phenotype characterization may facilitate the elucidation of the genetic background of the so called "FMF without MEFV mutations". In this study we clinically and demographically characterize this subset.

methodsMEFV mutation-negative FMF and control patients were recruited randomly from a cohort followed in a dedicated FMF clinic. The control subjects comprised 2 groups: 1. typical population of FMF, consisting of genetically heterogeneous patients manifesting the classical spectrum of FMF phenotype and 2. a severe phenotype of FMF, consisting of FMF patients homozygous for the p.M694V mutation.

resultsForty-seven genetic-negative, 60 genetically heterogeneous and 57 p.M694V homozygous FMF patients were enrolled to the study. MEFV-mutation negative FMF patients showed a phenotype closely resembling that of the other 2 populations. It differed however from the p.M694V homozygous subset by its milder severity (using Mor et al. scoring method), as determined by the lower proportion of patients with chest and erysipelas like attacks, lower frequency of some of the chronic manifestations, lower colchicine dose and older age of disease onset.

conclusionsMEFV mutation-negative FMF by virtue of its classical FMF phenotype is probably associated with a genetic defect upstream or downstream to MEFV related metabolic pathway.

Indexed as

AdolescentAdultCase-Control StudiesChildChild, PreschoolColchicineCytoskeletal ProteinsFamilial Mediterranean FeverGenotypeHumansMutationPyrinTubulin ModulatorsYoung AdultColchicineCytoskeletal ProteinsMEFV protein, humanPyrinTubulin Modulators

Identifiers

PMID25887307
PMCPMC4377009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.